CanSino and Moderna’s race for a vaccine; WHO’s mass international clinical trial; the “state of the world” in brief. The ASG global COVID-19 update

A detailed analysis of the global progression of the pandemic, and of government’s responses, prepared by the global strategic advisory and commercial diplomacy firm, Albright Stonebridge Group.

Key Takeaways

  • CanSino Biologics’ vaccine candidate has been approved for use by the Chinese military, while U.S.-based Moderna Inc. announced yesterday that it would begin final stage trials of its vaccine this month. If all goes well, a working vaccine could be available in early 2021.
  • As evidence mounts that hydroxychloroquine may do more harm than good as a prophylactic, it has been removed from many therapeutic trackers.
  • The World Health Organization has started the Solidarity Trial to initiate a mass international clinical trial to help find an effective treatment for the virus. Earlier this month, they presented their candidates and over 100 countries have joined or plan to join the trials in an effort to unify international standards of care. There are almost 6,000 participants currently enrolled in the study from 21 countries.
  • Across the globe
    • The U.S. continues to struggle to control its outbreak, which is on a scale seen in few other countries in the world. Earlier this week, new cases in three U.S. states alone accounted for 18% of the world’s daily global total.
    • In Beijing, the localized Covid-19 outbreak that began on June 11 has subsided, with no new cases reported for eight consecutive days. From June 11-July 2, the city conducted nucleic acid detection tests on more than 11 million residents.
    • Melbourne, Australia’s second largest city, went back into lockdown on July 8 in order to contain a new outbreak, forcing nearly five million Australians to stay home for all but essential activities.
    • Despite the recent surge, the Japanese government is pushing forward with reopening the economy, as it expands testing and contact tracing efforts.
    • Spain has re-imposed local restrictions in several regions after new outbreaks.
  • Latam
    • Brazil is the second-hardest hit of any country in the world, reporting more than 1.93 million cases and 74,133 deaths. Yet many regions in Brazil, including São Paulo and Rio de Janeiro, have reopened or are in the process of reopening.
    • Chile’s original “dynamic quarantine” strategy failed to contain the virus’ spread, and the country has imposed one of the strictest quarantine orders in the world, with 51% of its population under lockdown.
    • Peru’s initially strong response did little to mitigate the spread of the virus, with the country now reporting the world’s fifth-highest caseload. Peru opted to reopen.

Read the full report here.


Nature’s Currency: How Biodiversity Credits are Reshaping Conservation

By Victoria Galeano* Imagine sipping your morning coffee in a...

“Latin America, the vision of its leaders” A book by Andrés Rugeles and 100 regional leaders

The Colombian Andrés Rugeles has achieved an almost impossible...

Global Tourism Industry on Track for Full Recovery by 2024

The global tourism industry is set to reach, and possibly surpass, pre-pandemic levels by the end of 2024, according to the World Economic Forum (WEF). Five years post-COVID-19, the sector is experiencing a robust resurgence driven by a surge in international travel, improved air connectivity, and strong rebounds in key regions. However, global dynamics must be managed carefully to ensure stable and continuous growth. In 2023, international tourism reached 88% of its 2019 levels, a significant recovery favored by the reopening of Asian markets, as highlighted by the United Nations World Tourism Organization (UNWTO). The Middle East led the way, surpassing pre-pandemic levels by around 20%, with Europe, the Americas, and Africa following close behind at approximately 90% of their […]